Clinical Trials Browser

INDUSTRY × Recurrence × Sirolimus × Clear all

NCT06743503 2025-09-18

UB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell Malignancies

Phase 1 Recruiting

Recurrence